Reporting of Determinants of Health Inequities in Rheumatoid Arthritis Randomized Controlled Trials in Canada: A Scoping Review
Authors' conclusion
This scoping review suggests limited reporting on determinants of health inequities in RCTs for RA in Canada.
Study context
- Population
- Randomized controlled trials (RCTs) of pharmacologic or nonpharmacologic interventions including participants with rheumatoid arthritis (RA), conducted in Canada (Medline, Embase 1990 to December 2021; CENTRAL inception to December 2021)eligible studies of 6,290 records
- Participants
- 42 participants
- Outcome
- Reporting of determinants of health inequities (PROGRESS-Plus) in RA RCTs in Canada
Methodological detailsArksey and O'Malley framework, PROGRESS-Plus framework for data extraction, Studies grouped in 3 time periods: before 2000; 2000-2010; 2011 to present
- Arksey and O'Malley framework
- PROGRESS-Plus framework for data extraction
- Studies grouped in 3 time periods: before 2000; 2000-2010; 2011 to present
Main finding
As reported in the abstract
Reporting of determinants of health inequities (PROGRESS-Plus) in Canadian RA RCTs
- Sex and age reported (most widely reported determinants), studies
- 41
- Race reported, studies
- 15
- Education reported, studies
- 11
- Socioeconomic status reported, studies
- 7
- Occupation reported, studies
- 6
Original publication
Reporting of Determinants of Health Inequities in Rheumatoid Arthritis Randomized Controlled Trials in Canada: A Scoping Review. Arthritis Care Res (Hoboken). Published 24 August 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →